Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NCOA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CD200R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4683 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF334 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATXN1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MADCAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SCARA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YTHDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927769 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00458 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF234 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRCAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP10B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4B_2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on